Description

Histological assessment of colonic inflammation in IL-10-deficient mice treated with the glutaminase inhibitor BPTES. H&E staining reveals reduced mucosal damage and inflammatory infiltration in treated animals.

Figure 1

Micrograph

Source Paper

Spontaneous colitis in IL-10-deficient mice was ameliorated via inhibiting glutaminase1.

Journal of cellular and molecular medicine (2019)

PMID: 31211512

DOI: 10.1111/jcmm.14471

Cite This Figure

![Figure 1: Histological assessment of colonic inflammation in IL-10-deficient mice treated with the glutaminase inhibitor BPTES. H&E staining reveals reduced mucosal damage and inflammatory infiltration in treated animals.]()

> Source: Jing Li et al. "Spontaneous colitis in IL-10-deficient mice was ameliorated via inhibiting gluta." *Journal of cellular and molecular medicine*, 2019. PMID: [31211512](https://pubmed.ncbi.nlm.nih.gov/31211512/)

<figure>
  <img src="" alt="Histological assessment of colonic inflammation in IL-10-deficient mice treated with the glutaminase inhibitor BPTES. H&E staining reveals reduced mucosal damage and inflammatory infiltration in treated animals." />
  <figcaption>Figure 1. Histological assessment of colonic inflammation in IL-10-deficient mice treated with the glutaminase inhibitor BPTES. H&E staining reveals reduced mucosal damage and inflammatory infiltration in treated animals.<br>  Source: Jing Li et al. "Spontaneous colitis in IL-10-deficient mice was ameliorated via inhibiting gluta." <em>Journal of cellular and molecular medicine</em>, 2019. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31211512/">31211512</a></figcaption>
</figure>

Preuves associées

L-Glutamine pour Crohn's Disease

Note C · 3 études